Aspen Aerogels (NYSE: ASPN) reported Q1 EPS of ($0.02), $0.11 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $94.5 million versus the consensus estimate of $75.01 million.

GUIDANCE:

Aspen Aerogels sees FY2024 EPS of $0.03. Aspen Aerogels sees FY2024 revenue of $380 million, versus the consensus of $362.1 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.